Technological advances in closed-loop drug-device delivery systems that improve patient experience and lead to clinical adoption in diabetes, oncology and neurology with representatives from Abbott, Novo Nordisk, Key Tech, Beta Bionics and MIT.
Lead Podcast

Featured Podcasts
Podcasts by Category
Modernizing Clinical Trial Operations
View All
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives

Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges

Directors' Talk DPHARM 2025 - Pharma from the Trenches; Part II

Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?
Immuno-Oncology and Cell Therapy
View All
Stanford's Dr Crystal Mackall on CAR T for Solid Tumors and Cell Therapy's Future, from IO360º 2025

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

2025 Biotech Markets & Immuno-Oncology Outlook

Addressing the Realities of Scaling T-Cell Therapies for Patient Access and Affordability
Drug Delivery
View AllPatients as Partners in Clinical Research and Patient Access
View All
Ensuring Continuity in Patient Insights to Strengthen Medicine Development

Catalyzing Change: The Business Imperative of Patient-Centric Drug Development

Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
Sponsored

The Current Status of Patient Centricity in Medicine Development
Sponsored
Biotech CMO/R&D Leadership
View AllCRAACO: Clinical Research as a Care Option
View All
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives

Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges

What to Expect at the CRAACO: Clinical Research as a Care Option 2025 Event
